Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Docetaxel

3

I.a Pneumonitis (ILD), acute and/or severe (may cause ARDS)

2
Last update : 09/06/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Paclitaxel
5

Publications

Docetaxel-induced interstitial lung disease among patients with breast cancer: a case series and review of literature.
Respirology case reports 2021 Jul;9;e00802 2021 Jul
Fatal hypersensitivity pneumonitis associated with docetaxel.
Tumori 2013;99;e100-3 2013
Acute interstitial pneumopathy associated with docetaxel hypersensitivity.
Onkologie 2004 Dec;27;563-5 2004 Dec
Severe interstitial pneumonitis associated with docetaxel administration.
Cancer 2002 Feb 01;94;847-53 2002 Feb 01
Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere).
British journal of cancer 2001 Nov 02;85;1247-50 2001 Nov 02
[Acute diffuse interstitial pneumopathy following docetaxel (Taxotère). Apropos of 2 cases].
Revue des maladies respiratoires 1998 Apr;15;199-203 1998 Apr

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies